After the acquisition of 92.19% of the share capital and 91.56% of the voting rights of
As a result, Stryker intends to file, within the coming weeks, a proposed public buy-out offer for all the outstanding shares it does not own for a price per share of
In accordance with Article 261-1, I and II of the general regulation of the AMF, the board of directors of
The squeeze-out is expected to occur during Q2 2018.
The suspension of trading of
This press release contains information that includes or is based on forward-looking statements within the meaning of the federal securities law that are subject to various risks and uncertainties that could cause our actual results to differ materially from those expressed or implied in such statements. Such factors include, but are not limited to: our ability to file, conduct and close the public buy-out offer and implement the squeeze-out; delays in consummating the offer or the squeeze-out; weakening of economic conditions that could adversely affect the level of demand for our products; pricing pressures generally, including cost-containment measures that could adversely affect the price of or demand for our products; changes in foreign exchange markets; legislative and regulatory actions; unanticipated issues arising in connection with clinical studies and otherwise that affect
Stryker is one of the world's leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes. More information is available at www.stryker.com.
Other important information
This press release is for information purposes only and does not constitute an offer to purchase, or a solicitation of an offer to sale, any securities of
For investor inquiries please contact:
For media inquiries please contact:
This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Vice President, Strategy & Investor Relations
2825 Airview Boulevard
Kalamazoo, MI 49002